FIELD: chemistry.
SUBSTANCE: invention refers to new compounds for cyclin-dependent kinase inhibition, in particular, chromenone derivatives by formula Ic: (la) where R1, R2, R3, R4, R5, R6, R7 and A take on values specified in formula of invention. Invention also refers to technology of these compounds, as well as to application of these compounds for medicines intended for cyclin-dependent kinase inhibition and cell proliferation inhibition, used for treatment and prevention of various proliferative diseases. Invention also concerns compositions containing these compounds alone or in combination with other active agent, mixed or otherwise reacted with inert carrier, in particular, pharmaceutical compositions containing these compounds alone or in combination with other active agent, together with pharmaceutically acceptable carriers and adjuvants.
EFFECT: production of new compounds for cyclin-dependent kinase inhibition used for cyclin-dependent kinase inhibition and cell proliferation inhibition used for treatment and prevention of various proliferative diseases.
21 cl, 6 dwg, 2 tbl, 149 ex
Title | Year | Author | Number |
---|---|---|---|
ENANTIOMERICALLY PURE FLAVONE DERIVATIVES FOR TREATMENT OF PROLIFERATIVE DISORDERS AND METHODS OF THEIR OBTAINING | 2006 |
|
RU2418786C2 |
CHROMONE DERIVATIVES, METHOD FOR PREPARING THEM AND THERAPEUTIC USES THEREOF | 2010 |
|
RU2545214C2 |
METHOD OF ENANTIOSELECTIVE SYNTHESIS OF INTERMEDIATE COMPOUNDS USED IN SYNTHESIS OF FLAVONE-SUBSTITUTED PYRROLIDINES | 2006 |
|
RU2404965C2 |
4-HYDROXY-3-QUINOLINECARBOXAMIDES AND HYDRAZIDES, PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD BASED ON THEREOF | 1998 |
|
RU2220960C2 |
COUMARONE DERIVATIVES ELICITING COMT-INHIBITING ACTIVITY | 2001 |
|
RU2282627C2 |
METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION | 2004 |
|
RU2330682C2 |
TRIAZOLE DERIVATIVES | 2006 |
|
RU2416605C2 |
QUINAZOLINONE DERIVATIVES AND THEIR USE AS AGONISTS OF CANNABINOID (CB) RECEPTOR | 2003 |
|
RU2374235C2 |
OXAZOLIDINE ANTIBIOTICS | 2008 |
|
RU2470022C2 |
PHARMACEUTICAL AGENT CONTAINING INHIBITOR OF SODIUM-DEPENDENT PHOSPHATE CARRIER | 2015 |
|
RU2740008C2 |
Authors
Dates
2008-09-27—Published
2003-07-07—Filed